Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecasts to 2025
Instant Answers with GPT - Ask Now!
Ask real questions. Get complete answers !
Generating Response ...The global cell-based assays market boasts a total value of $14.9 billion in 2020 and is projected to register a growth rate of 8.1% to reach a value of $22.0 billion by 2025. The increasing preference for cell-based assays, the increase in the number of drug discovery activities, and surging research funding are all driving this industry forward. However, reagent restrictions and high instrument costs are two main challenges limiting the market's growth.
To know about the assumptions considered for the study, download the pdf brochure
Cell-Based Assays Market Dynamics
Drivers: Growing preference for cell-based assays in drug discovery
Cell-based assays are key components in the drug development process. Cell-based assays have several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays. It is also not possible to prepare or purify every target for biochemical measurement, which is a major factor limiting the applications of biochemical assays. As a result, pharmaceutical & biotechnology companies as well as CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery.
The conventional methods of toxicity and drug safety assessment (involving animal testing) are expensive, time-consuming, and offer low-throughput. In this regard, modern cell-based assays merge the advantages of cell cultures and animal models to allow researchers to identify problems with lead compounds in early screening, ensuring greater efficiency in the drug discovery and development process. Additionally, the physiological relevance of cell-based assays, as well as their ability to provide efficient, cost-effective, and accelerated drug discovery solutions, has also fueled their greater adoption among end users.
Resatraints: High cost of instruments and restrictions on reagent use
The introduction of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell-based assays has increased their reliability. However, these technologies have also resulted in a significant increase in the cost of instruments. Moreover, the time and cost involved in each HTS process are directly proportional to the target molecule’s complexity; consequently, the higher the complexity, the greater the cost. In biopharmaceutical companies, the overall cost of production of biopharmaceuticals has increased considerably due to the use of these expensive systems. Academic research laboratories find it difficult to afford such expensive instruments due to budgetary restrictions. Maintenance costs and other indirect expenses result in an overall increase in the total cost of ownership of these instruments.
The growth of the reagents market is restricted by a different factor—product end-user licenses restrict the use of reagent kits only to specified assays. Due to this, even though better and superior reagents are available in the market, customers are restricted to using only those reagents specified in the license agreement. This may act as a barrier to the growth of the cell-based assays market.
Opportunities: Emerging markets
Emerging countries in Asia are expected to offer significant growth opportunities for players operating in the cell-based assays market owing to the low labor and raw material costs, increased risk of pandemics (such as swine flu and COVID-19), growth in the number of research activities, and technological advancements in the end-use sectors for cell-based assays in these countries.
A number of Asian governments have increased their focus on life science research over the last few years. For instance, the Global Health Innovative Technology (GHIT) Fund is a public-private partnership in Japan that funds various R&D activities for drug discovery, which also includes the screening of compound libraries related to various infectious diseases. R&D spending for new drug development is a critical growth driver for the global cell-based assays market. According to estimates from the World Bank, the R&D spending in emerging economies in Asia and RoW has surpassed that of North America and Europe. Additionally, the increasing number of pharmaceutical companies and CROs—key end-users of cell-based assays—in these countries is expected to offer potential growth opportunities for manufacturers of cell-based assays.
“Consumables are expected to fuel the growth of the cell-based assays market over the forecast period.”
By product, the cell-based assays market is segmented into consumables, instruments, and services. The consumables segment accounted for majority of the market share in 2019 and is anticipated to grow at a CAGR of 6.6% during the forecast period. This growth can be attributed to the increasing number of drug discovery activities, especially in emerging markets.
“Increasing use of cell-based assays in drug discovery to drive market growth during the forecast period”
Based on application, the cell-based assays market is segmented into drug discovery, basic research and other applications such as quality check among others. The drug discovery segment is anticipated to drive growth in the market at a CAGR of 7.5% over the forecast period. This growth can be attributed to the increase in R&D investment by biopharmaceutical companies.
By end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the cell-based assays market in 2019.
Based on end users, the cell-based assays market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes. Pharmaceutical & biotechnology companies dominated the market in 2019. The large share of this segment can be attributed to the increase in R&D expenditure, the growing number of drug discovery projects, and the adoption of strategic approaches such as collaborations to develop drug candidates.
“Asia Pacific to grow at the highest rate during the forecast period (2019–2024)”
The cell-based assays market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America dominated the market in 2019, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the increasing R&D investment by government and increasing infrastructural development in the region.
Cell-based Assays Market Key Players
Some of the prominent players in the cell-based assays market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).
Thermo Fisher Scientific is the leading player in the cell-based assays market. The company offers a range of assay kits and cell lines used in cell-based assays. The company‘s large share in this market can be attributed to its extensive product portfolio and strong sales & distribution network. Thermo Fisher focuses on developed and emerging markets in order to generate a significant amount of its revenue. The company registered 57% of its total revenue from the US and China together. In order to maintain its leading position in the market, the company also invests 3–5% of its total revenue on R&D.
Danaher is another leading player in the cell-based assays market. The company offers a wide range of instruments and consumables used in cell-based assays. The company focuses on launching new products in the market. The company’s strong presence and wide distribution channels across the globe have helped it to maintain a leading position in the market. Approximately 40.2% of the company’s revenue was generated from North America in 2021. The company focuses on organic and inorganic strategies to strengthen its position in the market.
Cell based Assays Market Scope
|
Report Metrics |
Details |
|
Market Size value 2025 |
USD 22.0 billion |
|
Growth Rate |
8.1% Compound Annual Growth Rate (CAGR) |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
|
|
Table of Content |
|
|
Market Segmentation |
Product, Application, End User And Regional. |
|
Cell based Assays Market Growth Drivers |
Growing preference for cell-based assays in drug discovery |
|
Cell based Assays Market Growth Opportunities |
Emerging markets |
|
Report Highlights |
|
|
Geographies Covered |
North America, Europe, APAC, MEA, and Latin America |
The study categorizes the cell-based assays market into the following segments and subsegments:
By Product And Service
-
Consumables
- Reagents
-
Assay Kits
- Reporter Gene Assays
- Cell Growth Assays
- Second Messenger Assays
- Cell Death Assays
- Other Assay Kits
-
Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Other Consumables
- Instruments & Software
- Services
By Type
-
Drug Discovery
- Toxicity Studies
- Pharmacodynamic Studies
- Pharmacokinetic Studies
- Basic Research
- Other Applications
By End User
- Pharmaceutical & Biopharmaceutical Companies
- CROs
- Academic & Research Institutes
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- The Middle East and Africa
Recent Developments
- In 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System.
- In 2020, Thermo Fisher Scientific (US) acquired Phitonex, Inc. (US). The acquisition of spectral dye platform manufacturer Phitonex will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities in protein and cell analysis research.
- In 2020, Charles River Laboratories entered into a multi-year drug discovery collaboration with Karuna Therapeutics, a US-based CRO, to expand its drug discovery capabilities.
- In 2020, Danaher Corporation completed the acquisition of GE Healthcare’s biopharma business and renamed as Cytiva.
- In 2018, Lonza Group AG (Switzerland) established its Collaborative Innovation Center in the new Life Science Park on the outskirts of Haifa, Israel. This center focuses on the R&D projects of Lonza’s Pharma Biotech & Nutrition segment.
Frequently Asked Questions (FAQs):
What is the size of Cell-based Assays Market?
The global cell-based assays market boasts a total value of $14.9 billion in 2020 and is projected to register a growth rate of 8.1% to reach a value of $22.0 billion by 2025.
What are the major growth factors of Cell-based Assays Market?
The increasing preference for cell-based assays, the increase in the number of drug discovery activities, and surging research funding are all driving this industry forward. However, reagent restrictions and high instrument costs are two main challenges limiting the market's growth.
Who all are the prominent players of Cell-based Assays Market?
Some of the prominent players in the cell-based assays market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 1 PRIMARY SOURCES
FIGURE 2 CELL-BASED ASSAYS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2019
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2019
FIGURE 5 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS, 2020–2025
FIGURE 6 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 CELL-BASED ASSAYS MARKET, BY END USER (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT: CELL-BASED ASSAYS MARKET
4 PREMIUM INSIGHTS (Page No. - 47)
4.1 CELL-BASED ASSAYS MARKET OVERVIEW
FIGURE 12 RISING DRUG DISCOVERY ACTIVITY IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2019)
FIGURE 13 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2019
4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION (2019)
FIGURE 14 DRUG DISCOVERY COMMANDED THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN 2019
4.4 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA IS THE FASTEST-GROWING MARKET FOR CELL-BASED ASSAYS
5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Growing preference for cell-based assays in drug discovery
5.2.1.2 Increasing funding for cell-based research
5.2.1.3 Growth in the number of drug discovery activities
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and restrictions on reagent use
5.2.2.2 Lack of infrastructure for cell-based research in emerging economies
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Growing risk of pandemics and communicable diseases
5.2.3.3 Application of novel cell-based assays in cancer research
5.3 IMPACT OF COVID-19 ON THE CELL-BASED ASSAYS MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 17 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 18 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 19 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE (Page No. - 57)
6.1 INTRODUCTION
TABLE 1 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 2 CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 3 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 4 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.2.1 REAGENTS
6.2.1.1 Expanded applications of reagents propel market growth for the segment
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 EUROPE: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 ASSAY KITS
TABLE 11 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.2.2.1 Reporter gene assays
6.2.2.1.1 Reporter gene assays can be used with limited resources to establish HTS platforms, representing opportunities for small laboratories with limited resources
TABLE 16 REPORTER GENE ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 NORTH AMERICA: REPORTER GENE ASSAYS REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.2 Cell growth assays
6.2.2.2.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
TABLE 20 CELL GROWTH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.3 Second messenger assays
6.2.2.3.1 These assays are used to detect and characterize all compound classes
TABLE 24 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.4 Cell death assays
6.2.2.4.1 Cell death quantification is essential to identify how potential drugs could inhibit or enhance molecular targets
TABLE 28 CELL DEATH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.5 Other assay kits
TABLE 32 OTHER ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.3 MICROPLATES
6.2.3.1 Extensive use of microplates for assay development is encouraging the consumption of these products
TABLE 36 MICROPLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.4 CELL LINES
TABLE 40 CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 EUROPE: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.2.4.1 Immortalized cell lines
6.2.4.1.1 Immortalized cell lines are widely used owing to their ease of use, cost-effectiveness, and high availability of material
TABLE 45 IMMORTALIZED CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.4.2 Primary cell lines
6.2.4.2.1 Primary cell lines find demand in a range of applications
TABLE 49 PRIMARY CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 50 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.4.3 Stem cell lines
6.2.4.3.1 Stem cell lines find applications in therapy development and regenerative medicine
TABLE 53 STEM CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.5 PROBES & LABELS
6.2.5.1 Effective labeling of cells helps in studying cellular events
TABLE 57 PROBES & LABELS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.6 OTHER CONSUMABLES
TABLE 61 OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS & SOFTWARE
6.3.1 TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION IN INSTRUMENTS AND RISING USE OF SOFTWARE DRIVE THE GROWTH OF THE SEGMENT
TABLE 65 INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 66 NORTH AMERICA: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 ASIA PACIFIC: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 RISING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE SEGMENT GROWTH
TABLE 69 SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 CELL-BASED ASSAYS MARKET, BY APPLICATION (Page No. - 93)
7.1 INTRODUCTION
TABLE 73 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.2 DRUG DISCOVERY
TABLE 74 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 75 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
7.2.1 TOXICITY STUDIES
7.2.1.1 Increasing adoption of high-content screening for cytotoxicity testing to fuel growth in this segment
TABLE 79 TOXICITY STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 80 NORTH AMERICA: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 81 EUROPE: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 82 ASIA PACIFIC: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.2 PHARMACOKINETIC STUDIES
7.2.2.1 Rising importance of ADME studies in pharmacokinetics to propel the demand for advanced cell-based assay technologies
TABLE 83 PHARMACOKINETIC STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 84 NORTH AMERICA: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 85 EUROPE: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.3 PHARMACODYNAMIC STUDIES
7.2.3.1 Expanded use of cell-based assays to study pharmacodynamics to propel the growth of the segment
TABLE 87 PHARMACODYNAMIC STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 EUROPE: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90 ASIA PACIFIC: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 BASIC RESEARCH
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
TABLE 91 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 95 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 96 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 97 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
8 CELL-BASED ASSAYS MARKET, BY END USER (Page No. - 109)
8.1 INTRODUCTION
TABLE 99 CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1 GROWING R&D ACTIVITIES TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
TABLE 100 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 101 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,2018–2025 (USD MILLION
TABLE 102 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.3.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS
TABLE 104 RECENT MERGERS & ACQUISITIONS AMONG CONTRACT RESEARCH ORGANIZATIONS
TABLE 105 CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 106 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 EUROPE: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
TABLE 109 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
9 CELL-BASED ASSAYS MARKET, BY REGION (Page No. - 119)
9.1 INTRODUCTION
TABLE 113 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 114 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 116 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 120 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 With growing R&D funding and recent drug approvals, the US dominates the North American cell-based assays market
TABLE 122 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 123 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 US: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 US: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 127 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 US: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Strategic partnerships and collaborations are supporting the growth of the market in Canada
TABLE 129 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 130 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 CANADA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 CANADA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 134 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 137 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 138 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 EUROPE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,2018–2025 (USD MILLION)
TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates the cell-based assays market in Europe
TABLE 144 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 145 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 GERMANY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 GERMANY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 149 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Focus on cancer research funding will increase the demand for cell-based assays in the country
TABLE 151 UK: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 152 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 UK: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 UK: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 156 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increase in R&D funding to drive the growth of the market
TABLE 158 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 159 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 FRANCE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 FRANCE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 163 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Strategic collaborations in drug discovery have promoted the growth of the cell-based assays market in Italy
TABLE 165 ITALY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 166 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 ITALY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 ITALY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 170 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 ITALY: CELL-BASED ASSAYS MARKET, BY END USER,2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Availability of funding from private and public organizations is aiding the market growth
TABLE 172 SPAIN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 173 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 SPAIN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 SPAIN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 176 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 177 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 179 ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 180 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 ROE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 ROE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 184 ROE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 186 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 187 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 188 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 192 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 193 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Rising R&D capabilities and accelerated drug discovery have created a demand for cell-based assays products and services
TABLE 194 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 195 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 CHINA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 CHINA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 199 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 200 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Government programs to encourage drug discovery has increased the demand for cell-based assays in Japan
TABLE 201 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 202 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 JAPAN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 JAPAN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 206 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Market growth in India is attributed to increasing investments in R&D and funding for life sciences research
TABLE 208 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 209 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 INDIA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 INDIA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 213 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 215 ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 216 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 ROAPAC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 ROAPAC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 220 ROAPAC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING NUMBER OF CLINICAL TRIAL SITES AND GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
TABLE 222 LATAM: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 223 LATAM: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 LATAM: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 LATAM: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 226 LATAM: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 227 LATAM: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 228 LATAM: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT EFFORTS TO INCREASE RESEARCH WILL FUEL THE DEMAND FOR CELL-BASED ASSAYS IN THE REGION
TABLE 229 MEA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 230 MEA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 MEA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 MEA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 MEA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 234 MEA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 MEA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 175)
10.1 OVERVIEW
FIGURE 22 MARKET EVALUATION FRAMEWORK
10.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 23 MARKET SHARE ANALYSIS: 2019
TABLE 236 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.3 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2019
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PERVASIVE COMPANIES
10.3.4 EMERGING COMPANIES
FIGURE 24 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019
10.4 CELL-BASED ASSAYS MARKET: START-UP/SME EVALUATION MATRIX, 2019
10.4.1 PROGRESSIVE COMPANIES
10.4.2 STARTING BLOCKS
10.4.3 RESPONSIVE COMPANIES
10.4.4 DYNAMIC COMPANIES
FIGURE 25 CELL-BASED ASSAYS MARKET: STARTUP/SME EVALUATION MATRIX, 2019
10.5 KEY MARKET DEVELOPMENTS
10.5.1 KEY PRODUCT LAUNCHES
10.5.2 KEY ACQUISITIONS
10.5.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
10.5.4 KEY EXPANSIONS
11 COMPANY PROFILES (Page No. - 184)
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
11.1 THERMO FISHER SCIENTIFIC
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.2 DANAHER CORPORATION
FIGURE 27 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
11.3 MERCK KGAA
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.4 BECTON, DICKINSON AND COMPANY
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.5 LONZA GROUP
FIGURE 30 LONZA GROUP AG: COMPANY SNAPSHOT
11.6 PERKINELMER
FIGURE 31 PERKINELMER: COMPANY SNAPSHOT (2019)
11.7 CHARLES RIVER LABORATORIES
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019)
11.8 EUROFINS SCIENTIFIC SE
FIGURE 33 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2019)
11.9 ENZO BIOCHEM
FIGURE 34 ENZO BIOCHEM: COMPANY SNAPSHOT (2019)
11.10 PROMEGA CORPORATION
11.11 CARNA BIOSCIENCES, INC.
FIGURE 35 CARNA BIOSCIENCES: COMPANY SNAPSHOT (2020)
11.12 CELL BIOLABS
11.13 CELL SIGNALING TECHNOLOGY
11.14 BIOAGILYTIX LABS INC.
11.15 REACTION BIOLOGY CORPORATION
11.16 AAT BIOQUEST, INC.
11.17 PBL ASSAY SCIENCE
11.18 INVIVOGEN
11.19 CA3 BIOSCIENCES INC. (NEUROMICS)
11.20 BPS BIOSCIENCE
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 233)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global cell-based assays market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the cell-based assays market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Data
The secondary sources referred to for this research study include publications from government sources, such as the American Society for Cell Biology (ASCB), Federal Ministry of Education and Research (BMBF), Center for Commercialization of Regenerative Medicine (CCRM), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Agency for Research on Cancer (IARC), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Cancer Research Fund International (WCRF), World Health Organization (WHO), and Eurostat, among others. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global cell-based assays market, which was validated through primary research.
Primary Data
Extensive primary research was conducted after acquiring basic knowledge about the global cell-based assays market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in contract research organizations) and supply side (such as C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering cell-based assays) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Primary research was used in this report to:
- Validate the market segmentation defined through a product and service portfolio assessment of the leading players in the cell-based assays market
- Understand key industry trends and issues defining the strategic growth objectives of market players
- Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, and opportunities)
- Validate assumptions for the market sizing and forecasting model used for this study
- Understand the market position of leading players in the cell-based assays market and their market shares/rankings
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the cell-based assays market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell-based assays market
Report Objectives
- To define, describe, and forecast the global cell-based assays market based on product & service, application, end user, and region.
- To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, and opportunities).
- To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall cell-based assays market.
- To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
- To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To profile the key players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as new product & service launches; acquisitions; expansions; and partnerships, collaborations, and agreements
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the European cell-based assays market into countries from the Rest of Europe segment.
- Further breakdown of the Asia Pacific cell-based assays market into countries from the Rest of the APAC segment.
- Further breakdown of Latin America and the Middle East & Africa cell-based assays market into countries.
Company Information
Detailed analysis and profiling of additional market players (up to 5) inclusive of:
- Business Overview
- Financial Information
- Product Offered
- Developments (Last three years)
Growth opportunities and latent adjacency in Cell-based Assays Market